Security key
64130M209
NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock (NMTC)
CUSIP: 64130M209
Q4 2023 13F Holders as of 31 Dec 2023
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 2,862,898
- Total 13F value
- $4,523,339
- Share change
- +244,714
- Put/Call ratio
- 2.7%
- SEC-reported price per share
- $1.58
- Number of holders
- 20
- Value change
- +$578,694
- Number of buys
- 11
- Number of sells
- 6
- Shares outstanding
- 8,477,622
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2023
Institutions
20
Top holders
10
NMTC full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2024
Previous quarter: Q3 2023
NEUROONE MEDICAL TECHNOLOGIES Corp SEC filings
NEUROONE MEDICAL TECHNOLOGIES Corp company facts
Broader feeds
Reporting periods
Holder history for CUSIP 64130M209
Recent filing periods:
Ownership snapshot
Top reported holders of NMTC - NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Nantahala Capital Managem...
Disclosed value leader
Nantahala Capital Managem...
Comparable rows
15/15
Latest evidence
30 Sep 2023
13F
Lead comparable stake: 15%
Showing 1-6 of 15 holder rows.
Quick read
Nantahala Capital Management, LLC leads the comparable SEC ownership view at 15%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Nantahala Capital Management, LLC's linked filing trail.
Comparable ownership
Top 5
Nantahala Capital Management, LLC
15%
VANGUARD GROUP INC
5.2%
Walleye Capital LLC
2.7%
Mayo Clinic
2.1%
GEODE CAPITAL MANAGEMENT, LLC
2.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC |
13F
Company
|
15%
|
$1,113,000
1,250,000 shares
|
— | 30 Sep 2023 |
| VANGUARD GROUP INC |
13F
Company
|
5.2%
|
$391,314
439,481 shares
|
— | 30 Sep 2023 |
| Walleye Capital LLC |
13F
Company
|
2.7%
|
$201,191
225,956 shares
|
— | 30 Sep 2023 |
| Mayo Clinic |
13F
Company
|
2.1%
|
$161,834
181,754 shares
|
— | 30 Sep 2023 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
2.1%
|
$158,784
178,262 shares
|
— | 30 Sep 2023 |
| PERKINS CAPITAL MANAGEMENT INC |
13F
Company
|
1.8%
|
$134,000
150,000 shares
|
— | 30 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
20
Shares
2,862,898
Rows available
20
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
18
Q4 2023 holders
20
Holder diff
2
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 value | Q4 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend